Optimal Bayesian-feasible dose escalation for cancer phase I trials (Q1265963): Difference between revisions
From MaRDI portal
ReferenceBot (talk | contribs) Changed an Item |
Set OpenAlex properties. |
||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1016/s0167-7152(98)00016-9 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2063214645 / rank | |||
Normal rank | |||
Latest revision as of 09:20, 30 July 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal Bayesian-feasible dose escalation for cancer phase I trials |
scientific article |
Statements
Optimal Bayesian-feasible dose escalation for cancer phase I trials (English)
0 references
6 January 1999
0 references
Bayesian adaptive procedure
0 references
constrained optimization
0 references
Bayesian feasible scheme
0 references
dose escalation scheme
0 references
cancer phase I clinical trials
0 references
0 references
0 references
